ArticleEClinicalMedicine2023

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial.

John R Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.